JAK2 and systemic mastocytosis: Presence of large, hyperlobated and/or hyperchromatic megakaryocytes should prompt evaluation of the presence of JAK2, CALR or MPL mutations by NGS or PCR, as PMF may coexist with SM as an associated hematological neoplasm (SM-AHN) [49].